| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/13/2009 | CN101429161A Synthesis of PET imaging agent prosome isoquinoline methanamide derivant |
| 05/13/2009 | CN101428148A RGD polypeptide radiopharmaceuticals and preparation method thereof |
| 05/12/2009 | US7531563 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr) |
| 05/12/2009 | US7531500 Preventing airway mucus production by administration of EGF-R antagonists |
| 05/12/2009 | US7531162 Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation |
| 05/07/2009 | WO2009059107A1 Synthesis of ring b abeo-sterols as novel inhibitors of mycobacterium tuberculosis |
| 05/07/2009 | WO2009058851A2 Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
| 05/07/2009 | WO2009058754A1 Methods for imaging dopamine transporter level |
| 05/07/2009 | WO2009057578A1 Utilization of novel compounds with amyloid affinity and method of producing the same |
| 05/07/2009 | WO2009057577A1 Use of novel compound having affinity for amyloid, and process for production of the same |
| 05/07/2009 | WO2009057576A1 Use of novel compound having affinity for amyloid, and process for production of the same |
| 05/07/2009 | WO2009057575A1 Use of novel compound having affinity for amyloid, and process for production of the same |
| 05/07/2009 | WO2009056837A2 Materials and methods for medical imaging |
| 05/07/2009 | WO2009056268A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | WO2009055922A1 Labeled iodinated tropane formulation |
| 05/07/2009 | WO2009032160A3 Metalloprotein mri contrast agents and related methods |
| 05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
| 05/07/2009 | WO2009018335A9 Targeting brain cells via ophtalmic delivery |
| 05/07/2009 | WO2009012288A3 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
| 05/07/2009 | WO2008085564A3 Compositions and methods involving truncated recombinant seven g-protein coupled receptors |
| 05/07/2009 | WO2008010227A3 Imaging protocols |
| 05/07/2009 | US20090118702 Treatment Medium Delivery Device and Methods for Delivery of Such Treatment Mediums to the Eye Using such a Delivery Device |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/07/2009 | US20090117041 Radiologic Agents for Monitoring Alzheimer's Disease Progression and Evaluating a Response to Therapy and Processes for the Preparation of Such Agents |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | US20090117039 Charged biodegradable polymers for medical applications |
| 05/07/2009 | US20090117038 Breast Endothelial Cell Expression Patterns |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117036 Antibodies against gpr64 and uses thereof |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | US20090117034 Microorganisms for imaging and/or treatment of tumors |
| 05/07/2009 | US20090117033 Injectable biodegradable particles |
| 05/07/2009 | US20090117032 Imaging Agents for Early Detection and Monitoring of Cardiovascular Plaque |
| 05/07/2009 | US20090117031 Methods for Treating Glioma |
| 05/07/2009 | CA2704296A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | CA2704172A1 Use of novel compound having affinity for amyloid, and process for production of the same |
| 05/07/2009 | CA2704168A1 Use of novel compound having affinity for amyloid, and process for production of the same |
| 05/07/2009 | CA2704139A1 Utilization of novel compounds with amyloid affinity and method of producing the same |
| 05/07/2009 | CA2704137A1 Use of novel compound having affinity for amyloid, and process for production of the same |
| 05/07/2009 | CA2704104A1 Labeled iodinated tropane formulation |
| 05/07/2009 | CA2703563A1 Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
| 05/07/2009 | CA2700468A1 Methods for imaging dopamine transporter level |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2054894A2 Composition apparatus and method for use in imaging |
| 05/06/2009 | EP2054087A2 Polychromatic, diversely-sized particles for angiography |
| 05/06/2009 | EP1656160B1 Radioimmunoconjugates for targeted alpha therapy |
| 05/06/2009 | EP1385480B1 Liposomes |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof |
| 05/06/2009 | CN101423535A TcN(DGDTC)2 complexes as well as preparation method and use thereof |
| 05/06/2009 | CN101422623A 99mTc-Trodat-1 marked freeze-dry article medicine-box and preparation method |
| 04/30/2009 | WO2009055520A2 Fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 04/30/2009 | WO2009053644A2 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 04/30/2009 | WO2009033584A3 Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols |
| 04/30/2009 | WO2008109080A3 Nucleoside based proliferation imaging markers |
| 04/30/2009 | WO2008098112A3 Positron emission tomography imaging method |
| 04/30/2009 | WO2008083056A3 Ligands for imaging cardiac innervation |
| 04/30/2009 | WO2008011710A8 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 04/30/2009 | WO2008005514A3 Polychromatic, diversely-sized particles for angiography |
| 04/30/2009 | WO2006119438A3 Methods for measuring cholesterol metabolism and transport |
| 04/30/2009 | WO2006055879A3 Novel phosphorous containing steroid mimics |
| 04/30/2009 | US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/30/2009 | US20090110636 Fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 04/30/2009 | US20090110635 Methods for imaging dopamine transporter level |
| 04/30/2009 | US20090110634 Radiolabelled nanoparticles |
| 04/30/2009 | US20090110633 Nanocells for Diagnosis and Treatment of Diseases and Disorders |
| 04/30/2009 | US20090110632 Biological materials and uses thereof |
| 04/30/2009 | DE102008047781A1 Use of an oligopeptide comprising a specific amino acid-sequence for the diagnosis or therapy of a pathological condition in a mammal, preferably human, where the condition is identified by angiogenic processes |
| 04/30/2009 | CA2702919A1 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 04/29/2009 | EP2053129A2 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 04/29/2009 | EP2053063A1 Recognition molecules for treatment and detection of tumours |
| 04/29/2009 | EP2052742A1 Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination |
| 04/29/2009 | EP2052741A1 Radioactive material for inhibiting cancer and preparation method thereof |
| 04/29/2009 | EP1466172A4 Breath test |
| 04/29/2009 | CN101418020A <99m>Tc marked dimercapto succinate metronidazole esters complex and preparation method and use |
| 04/29/2009 | CN101417939A Method for preparing caprylic-1-<13>C |
| 04/29/2009 | CN101417135A Preparation method of biodegradable fallout radioactive material for treating cancer |
| 04/29/2009 | CN100482285C Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ED-B |
| 04/29/2009 | CN100482284C Tracer or labelled isotope microbubble reagent with target substance and usage thereof |
| 04/28/2009 | CA2567517C System, method, and computer program product for handling, mixing, dispensing, and injecting radiopharmaceutical agents |
| 04/28/2009 | CA2279530C A method for the detection and localization of ductal exocrine pancreas tumours |
| 04/23/2009 | WO2009050898A1 Therapeutic agent for colorectal cancer |
| 04/23/2009 | WO2009025914A3 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |
| 04/23/2009 | WO2007035906A3 Systems and methods for imaging-treatment of pain |
| 04/23/2009 | WO2007033090A3 Method for diagnosis of chronic allograft rejection |
| 04/23/2009 | WO2007024715A9 Dual variable domain immunoglobin and uses thereof |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090104183 Glue composition for lung volume reduction |
| 04/23/2009 | US20090104119 Dendrimer Based Compositions And Methods Of Using The Same |
| 04/23/2009 | US20090104118 Contrast agents for myocardial perfusion imaging |
| 04/23/2009 | US20090104117 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 04/23/2009 | US20090104116 Compounds for the inhibition of integrins and use thereof |
| 04/23/2009 | US20090104115 Cancerous disease modifying antibodies |
| 04/23/2009 | US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 04/23/2009 | US20090104113 Ionizing-radiation-responsive compositions, methods, and systems |
| 04/22/2009 | EP2049560A1 Process for preparing particles of proteinaceous material |
| 04/22/2009 | EP1897590A4 Method for carrying out a magnetic therapy of malignant neoplasms |
| 04/22/2009 | EP1531874B1 Embolic particles |